GAVILAX
- Product NDC
- 61919-542
- 11-digit product format
- 619190542
- Labeler code
- 61919
- Product ID
- 61919-542_f214c7ce-fa13-b6e1-e053-2a95a90a24a7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GAVILAX
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA091077
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- POLYETHYLENE GLYCOL 3350
- Active strength
- 17 g/17g
- Pharmacologic classes
- Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-542-51 | 61919054251 | 510 g in 1 BOTTLE (61919-542-51) | 510 g | 2015-01-01 | 0000-00-00 | No | No | Current |